Preview

 

In Touch

12/30/2020

Candace and Amelia Weir of Paradigm Capital Management explain the non-negotiable aspect of each of their investments, how they prospect for the “overlooked and underappreciated,” why they haven't done much trading in a volatile year, and why they think Genmark Diagnostics, Omnicell, Brooks Automation and Veeco Instruments offer upside value.

If you are a subscriber, log in to access the issue and bonus archive:

Not a subscriber? Subscribe today!

SUBSCRIBE NOW and receive a full year of Value Investor Insight — including weekly e-mail Bonus Content and access to all back issues — for only $349. That's a full year's worth of great investment ideas and wisdom for LESS THAN $30 PER MONTH!

Sign Up Now!